Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
Rapa Therapeutics LLC
Rapa Therapeutics LLC
National Institutes of Health Clinical Center (CC)
Biocon Limited
Duke University
Bristol-Myers Squibb
Peking University Cancer Hospital & Institute
M.D. Anderson Cancer Center
University Hospital, Grenoble
Kaiser Permanente